GlassScriptPhysician profile
Sandro Sarria
NPI 1881357432
$1,097.99
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $288 · 2023: $719 · 2024: $90.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $222.34 | 2022-2024 | Lyumjev, Mounjaro, Jardiance |
| Novo Nordisk INC | $176.94 | 2022-2023 | Ozempic, Rybelsus |
| Insulet Corporation | $101.22 | 2023-2024 | Omnipod |
| Antares Pharma, INC. | $87.92 | 2023 | Nocdurna, Xyosted, Tlando |
| Sanofi-Aventis U.S. LLC | $79.41 | 2022-2023 | |
| Embecta Corp. | $67.18 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Cequr Corporation | $60.20 | 2022-2023 | Cequr Simplicity |
| Tandem Diabetes Care, INC. | $49.69 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.62 | 2023 | Jardiance, Tradjenta, Trijardy Xr |
| Abbvie INC. | $31.01 | 2023 | |
| Amgen INC. | $30.91 | 2022-2024 | Evenity, Prolia |
| Amneal Pharmaceuticals LLC | $24.22 | 2023 | Unithroid |
| Ibsa Pharma INC. | $22.85 | 2023 | Tirosint, Licart |
| Xeris Pharmaceuticals, INC. | $22.09 | 2023 | Gvoke Hypopen |
| Pfizer INC. | $21.28 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $19.19 | 2023 | Afrezza |
| Corcept Therapeutics | $17.19 | 2023 | Korlym |
| Kyowa Kirin, INC. | $14.73 | 2023 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandro Sarria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.